Meta-Analysis of Effect of Dipeptidyl Peptidase-4 Inhibitors on Cardiovascular Risk in Type 2 Diabetes Mellitus

Study Questions:

What is the cardiovascular (CV) safety of dipeptidyl peptidase-4 (DPP4) inhibitors, a novel class of oral diabetic medications?